Dr. Peter Hotez has been officially recognized as part of the TIME100 Health list, an annual assessment by the publication identifying influential figures in the medical sector, according to TIME. This selection marks a significant acknowledgment of his professional trajectory and his persistent focus on addressing neglected tropical diseases and vaccine equity.

### Career Highlights and Professional Data While the announcement serves as a summary of his ongoing impact, Hotez’s career is defined by his commitment to infectious disease research and public science communication. His work involves coordinating with international health entities to streamline vaccine manufacturing processes, particularly for resource-limited regions.

| Attribute | Detail | | :--- | :--- | | Recognition | TIME100 Health | | Primary Field | Infectious Disease Research | | Focus Area | Tropical Diseases & Vaccines |

Dr. Hotez remains a prominent figure in the scientific community, often engaging with government agencies such as the National Institutes of Health (NIH) and various global health policy groups to discuss the mitigation of pandemic risks and the improvement of vaccine accessibility.

## Why It Matters Recognitions of this nature often influence the trajectory of public health funding and regulatory attention. By highlighting individuals like Hotez, institutions such as TIME signal to the broader healthcare sector that scientific advocacy and the pursuit of accessible pharmaceutical technology are central to global stability. This impact extends beyond clinical research; it directly influences how international bodies and governments allocate resources to fight regional disease outbreaks. When scientists of this stature are spotlighted, it frequently leads to increased interest from philanthropic and government entities regarding long-term health infrastructure investments.